Single Incision Laparoscopy
SIL
1 other identifier
interventional
24
1 country
1
Brief Summary
Laparoscopic surgery being performed with only one small incision via the umbilicus (belly button).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 4, 2008
CompletedFirst Posted
Study publicly available on registry
February 15, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedOctober 26, 2016
October 1, 2016
1.8 years
February 4, 2008
October 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the safety and efficacy of single incision laparoscopy
1 month
Study Arms (1)
1
EXPERIMENTALall subjects
Interventions
Surgery will be performed with ine laparoscopic incision
Eligibility Criteria
You may qualify if:
- Ages 18-75
- Patient has consented for a laparoscopic operation (independent of study participation)
- Attending surgeon decides operation can be completed via a single incision laparoscopic approach
You may not qualify if:
- Patients with BMI greater than 40
- Minors and cognitively impaired individuals
- Patients who are ASA class IV - Illness that is a constant threat to life
- Patients with ascites or Child's class C of liver failure
- Patients with known common bile duct stones
- Patients with coagulopathy, abnormal coagulation studies, or who take heparin, coumadin, Plavix (clopidogrel), aspirin, or other medication for the purpose of anti-coagulation and cannot be removed from the medication prior to the operation.
- Patients who present with incarcerated (irreducible) or strangulated hernias
- Patients with preoperative hematocrits less than 25.
- Preoperative hematocrit less than 25.
- Patients who have evidence of hemodynamic instability including systolic blood pressure greater than 200 or less than 80.
- Heart rate greater than 130 or less than 50. Respiratory rate greater than 35 or less than 6. Patients who are on continuous pressor drip for blood pressure support.
- Patients who present for emergency adrenalectomy.
- Patients with CT scan evidence of an abdominal abscess.
- Patients who present 48 hours after the onset of abdominal pain (appendectomy patients)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Diego
San Diego, California, 92103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Santiago Horgan, MD
University of California, San Diego
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
February 4, 2008
First Posted
February 15, 2008
Study Start
September 1, 2007
Primary Completion
July 1, 2009
Study Completion
February 1, 2010
Last Updated
October 26, 2016
Record last verified: 2016-10